Development and characterization of an open tubular column containing immobilized P-glycoprotein for rapid on-line screening for P-glycoprotein substrates

被引:46
|
作者
Moaddel, R
Bullock, PL
Wainer, IW [1 ]
机构
[1] NIA, Bioanalyt & Drug Discovery Unit, Intramural Res Program, Lab Clin Investigat,Gerontol Res Ctr, Baltimore, MD 21224 USA
[2] Purdue Pharma LP, Discovery Support, Ardsley, NY USA
关键词
substrates; ABC transporters; screening; P-glycoprotein;
D O I
10.1016/j.jchromb.2003.10.054
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cellular membranes from a cell line expressing P-glycoprotein (Pgp(+)) and from a cell line that does not express Pgp (Pgp(-)) were immobilized on the surface of glass capillaries (25 cm x 100 mum i.d.) by non-covalent interactions using the avidin-biotin coupling system to create two open tubular columns, Pgp(+)-OT and Pgp(-)-OT. Frontal displacement chromatography on the Pgp(+)-OT demonstrated that the immobilized Pgp retained its ability to specifically bind the known Pgp substrates vinblastin and ketoconazole. The calculated affinities, expressed as K-d, for vinblastin and ketoconazole were 97 nM and 12.1 muM, which were comparable with previously reported Kd values of 37 nM and 8.6 muM, respectively. The results confirm that the Pgp(+)-OT can be used to quantitatively estimate binding affinities for the Pgp. Frontal displacement chromatography on the Pgp(-)-OT demonstrated that the immobilized membranes retained the ability to bind some Pgp substrates, but that the binding was not due to specific binding to Pgp. A cohort of compounds containing high affinity Pgp substrates (vinblastin, prazosin) and moderate-low affinity Pgp substrates (doxorubicin, verapamil, ketoconazole) and a non-substrate (nicotine) were chromatographed on the Pgp(+)-OT and Pgp(-)-OT using fast frontal analysis and mass spectrometric detection. The results demonstrated that when the retention on the Pgp(+)-OT was corrected by subtraction of the retention on the Pgp(-)-OT, the test compounds could be accurately sorted into high, moderate-low and non-substrate categories. The data from the study indicates that a single 30-min parallel chromatographic experiment can be used to rank a compound based upon its relative affinity for the immobilized Pgp. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:255 / 263
页数:9
相关论文
共 50 条
  • [1] Identification of P-glycoprotein substrates using open tubular chromatography on an immobilized P-glycoprotein column:: Comparison of chromatographic results with Caco-2 permeability
    Moaddel, Ruin
    Hamid, Rachid
    Patel, Sharvil
    Bullock, Peter L.
    Wainer, Irving W.
    ANALYTICA CHIMICA ACTA, 2006, 578 (01) : 25 - 30
  • [2] Comparison of an open tubular column containing immobilized P-glycoprotein with Caco-2 cell monolayers.
    Moaddel, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P7 - P7
  • [3] Rapid identification of P-glycoprotein substrates and inhibitors
    Chang, Cheng
    Bahadduri, Praveen M.
    Polli, James E.
    Swaan, Peter W.
    Ekins, Sean
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (12) : 1976 - 1984
  • [4] PHOTOAFFINITY SUBSTRATES FOR P-GLYCOPROTEIN
    BECK, WT
    QIAN, XD
    BIOCHEMICAL PHARMACOLOGY, 1992, 43 (01) : 89 - 93
  • [5] Original Vinca Derivatives: From P-Glycoprotein Substrates to P-Glycoprotein Inhibitors
    Gherbovet, Olga
    Alvarez, Maria Concepcion Garcia
    Bignon, Jerome
    Roussi, Fanny
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (23) : 10774 - 10780
  • [6] Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs
    Kono, Yusuke
    Kawahara, Iichiro
    Shinozaki, Kohei
    Nomura, Ikuo
    Marutani, Honoka
    Yamamoto, Akira
    Fujita, Takuya
    PHARMACEUTICS, 2021, 13 (03)
  • [7] Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein
    Pauli-Magnus, C
    von Richter, O
    Burk, O
    Ziegler, A
    Mettang, T
    Eichelbaum, M
    Fromm, MF
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 293 (02): : 376 - 382
  • [8] Drugs as P-glycoprotein substrates, inhibitors, and inducers
    Kim, RB
    DRUG METABOLISM REVIEWS, 2002, 34 (1-2) : 47 - 54
  • [9] Detergents as intrinsic P-glycoprotein substrates and inhibitors
    Li-Blatter, Xiaochun
    Nervi, Pierluigi
    Seelig, Anna
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2009, 1788 (10): : 2335 - 2344
  • [10] Identification and characterization of primate P-glycoprotein
    Yimam, Mesfin
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2015, 6 (03) : 154 - 155